
Researchers enrolled 42 migraine patients to receive either 100 mg of CoQ10 three times each day, or a placebo. For one month all of the subjects received the placebo. Then, for the next three months, 21 received CoQ10 daily, while 21 received placebo. Subjects agreed to not use any other methods to prevent migraines during the study period. The results were dramatic. Researchers found that migraine frequency, total days with migraine, and total days with nausea were all significantly reduced in the CoQ10 group, compared to placebo. Overall, the incidence of migraines was almost cut in half in the CoQ10 group, while the reduction of migraines in the placebo group was less than 15 percent.
No comments:
Post a Comment